ADAR1 Capital Management’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.95M | Buy |
3,009,870
+1,943,561
| +182% | +$4.49M | 1.07% | 24 |
|
|
2025
Q1 | $1.48M | Buy |
1,066,309
+888,602
| +500% | +$1.24M | 0.28% | 62 |
|
|
2024
Q4 | $307K | Sell |
177,707
-73,693
| -29% | -$127K | 0.06% | 125 |
|
|
2024
Q3 | $505K | Buy |
251,400
+600
| +0.2% | +$1.21K | 0.08% | 105 |
|
|
2024
Q2 | $562K | Buy |
250,800
+207,300
| +477% | +$464K | 0.11% | 85 |
|
|
2024
Q1 | $125K | Sell |
43,500
-165,500
| -79% | -$475K | 0.03% | 127 |
|
|
2023
Q4 | $370K | Buy |
+209,000
| New | +$370K | 0.13% | 60 |
|